LETROZOLE DEXCEL

Nchi: Israeli

Lugha: Kiingereza

Chanzo: Ministry of Health

Nunua Sasa

Viambatanisho vya kazi:

LETROZOLE

Inapatikana kutoka:

DEXCEL LTD, ISRAEL

ATC kanuni:

L02BG04

Dawa fomu:

FILM COATED TABLETS

Tungo:

LETROZOLE 2.5 MG

Njia ya uendeshaji:

PER OS

Dawa ya aina:

Required

Viwandani na:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Kundi la matibabu:

LETROZOLE

Eneo la matibabu:

LETROZOLE

Matibabu dalili:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Idhini ya tarehe:

2016-02-29

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kiarabu 04-08-2020
Taarifa za kipeperushi Taarifa za kipeperushi Kiebrania 04-08-2020

Tafuta arifu zinazohusiana na bidhaa hii